綠城中國(03900.HK)終止購入百年人壽9億股股份交易
綠城中國(03900.HK)就附屬綠城房地產集團收購百年人壽9億股股份作進一步公布,指倘中銀保監並未於支付購買價後的規定期限內就收購事項發出批准,當股份轉讓協議終止,賣方須向綠城房產退還全部購買價。目前該批准尚未發出而終止有關交易。
因此,根據股份轉讓協議條款及條文,該協議終止,賣方將向綠城房產退還全部購買價。
公司預期終止股份轉讓協議將不會對集團的業務營運及財務狀況造成任何重大不利影響。(ta/ww)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.